KALA BIO, INC. Accrued Liabilities and Other Liabilities
KALA BIO, INC. (KALA) had Accrued Liabilities and Other Liabilities of $396.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2026-08-19
- 2026-06-30: Accrued Liabilities and Other Liabilities $396.00K.
- 2026-03-31: Accrued Liabilities and Other Liabilities $513.00K.
- 2025-12-31: Accrued Liabilities and Other Liabilities $1.51M.
- 2025-09-30: Accrued Liabilities and Other Liabilities $2.83M.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2026-06-30 | $396.00K 10-Q · filed 2026-08-19 |
| 2026-03-31 | $513.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $1.51M 10-Q · filed 2026-08-19 |
| 2025-09-30 | $2.83M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $3.84M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $4.04M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $4.97M 10-K · filed 2026-04-15 |
| 2023-12-31 | $6.02M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |